AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven

Go back to AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven
AVIANCA HOLDINGS S.A. (NYSE: AVH) Delayed: 0.88 --0 (-0%)
Previous Close $0.88    52 Week High $7.65 
Open $28.14    52 Week Low $3.40 
Day High $0.88    P/E N/A 
Day Low $0.88    EPS $0.00 
Volume 12,888       

(NASDAQ: RCEL) Delayed: 11.20 +0.26 (2.38%)
Previous Close $10.94    52 Week High
Open $10.99    52 Week Low
Day High $11.39    P/E N/A 
Day Low $10.80    EPS
Volume 301,851